Aakaar Medical Technologies Ltd. (NSE:AAKAAR)

NSE:AAKAAR Financials Overview

Financials in millions INR. Fiscal year is April - March.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Revenue Revenue Growth	669.64	669.64	615.83	461.11	327.85	194.65
Revenue Growth	13.11%	8.74%	33.55%	40.65%	68.42%	56.50%
Gross Profit Gross Profit Growth	387.15	387.15	353.15	251.04	177.77	103.61
Operating Income Operating Income Growth	101.93	101.93	96.75	49.47	36.15	24.45
Net Income Net Income Growth	66.38	66.38	60.33	28.7	21.53	18
Earnings Per Share EPS Growth	4.99	4.99	6.12	3.14	2.36	1.98
EPS Growth	19.08%	-18.46%	94.90%	33.05%	19.34%	230.59%

Revenue by Segment

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023
Period Ending	Mar 31, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023
Aesthetic Devices & Device Consumables Aesthetic Devices & Device Consumables Growth	73.57	73.57	85.47	118.13	92.36
Aesthetic Products Aesthetic Products Growth	596.08	596.08	530.36	342.99	235.49
Total Total Growth	669.64	669.64	615.83	461.11	327.85

Cash & Debt

Chart

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Investments Cash & Investments Growth	162.43	162.43	55.51	3	1.89	22.67
Total Debt Total Debt Growth	185.34	185.34	227.38	150.57	58.74	38.19
Net Cash (Debt) Net Cash Growth	-22.91	-22.91	-171.88	-147.57	-56.85	-15.53
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share Net Cash Per Share Growth	-1.72	-1.72	-17.44	-16.14	-6.23	-1.71

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Operating Cash Flow Operating Cash Flow Growth	-83.61	-83.61	-54.06	-80.44	-29.28	2.99
Capital Expenditures CapEx Growth	-5.78	-5.78	-0.84	-0.52	-2.64	-1.88
Free Cash Flow Free Cash Flow Growth	-89.4	-89.4	-54.9	-80.96	-31.91	1.11
Free Cash Flow Growth	-	-	-	-	-	-97.43%

Margins

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Gross Margin	57.81%	57.81%	57.34%	54.44%	54.22%	53.23%
Operating Margin	15.22%	15.22%	15.71%	10.73%	11.03%	12.56%
Pretax Margin	13.73%	13.73%	13.18%	8.43%	9.46%	12.59%
Profit Margin	9.91%	9.91%	9.80%	6.22%	6.57%	9.25%
FCF Margin	-13.35%	-13.35%	-8.91%	-17.56%	-9.73%	0.57%

Valuation

Chart

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Oct 3, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
PE Ratio	13.03	10.27	-	-	-	-
PS Ratio	1.38	1.02	-	-	-	-

Data Source: S&P Global Market Intelligence Last updated: Jun 3, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Oct 3, 2026

Data Sources Report a data error